Article metrics

Download PDFPDF

792 Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer

 

Online download statistics by month:

Online download statistics by month: November 2023 to October 2024

AbstractFullPdf
Nov 2023362034
Dec 2023286021
Jan 202413907
Feb 202413606
Mar 2024234013
Apr 2024184010
May 202426908
Jun 2024229013
Jul 202422408
Aug 202421507
Sep 202421009
Oct 2024222023
Total27100159